| Analysis | Metabolite Name | Measured Value | Units | subject type |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | RIBOSE 5-PHOSPHATE (CAS# 4300-28-1); (M-H)- | 1030 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | RIBOSE 5-PHOSPHATE (CAS# 4300-28-1); (M-H)- | 1118 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | RIBOSE 5-PHOSPHATE (CAS# 4300-28-1); (M-H)- | 1314 | Peak area | Severe disease |
| Reversed phase NEGATIVE ION MODE | RIBOSE 5-PHOSPHATE (CAS# 4300-28-1); (M-H)- | 2609 | Peak area | Healthy control |
| Reversed phase NEGATIVE ION MODE | RIBOSE 5-PHOSPHATE (CAS# 4300-28-1); (M-H)- | 5470 | Peak area | Mild disease |
| Reversed phase NEGATIVE ION MODE | RIBOSE 5-PHOSPHATE (CAS# 4300-28-1); (M-H)- | Peak area | Healthy control | |
| Reversed phase NEGATIVE ION MODE | RIBOSE 5-PHOSPHATE (CAS# 4300-28-1); (M-H)- | Peak area | Mild disease | |
| Reversed phase NEGATIVE ION MODE | RIBOSE 5-PHOSPHATE (CAS# 4300-28-1); (M-H)- | Peak area | Severe disease |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|